| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.12 | 0.4 |